Jury still out on successful Alzheimer’s treatment
Massive surge in fraudulent drugs around the world called a “public health emergency” by doctors
Mixed results for 2018 biopharma
US and emerging markets to accelerate pharma growth through 2023
Pharma companies increasing acquisitions
Biopharma R&D returns decline in 2018
Advances in CAR-T therapies now targeting solid tumors
Life science professionals cite real-world evidence as key factor in business strategy
Gene therapy faces challenges in its accessibility
New targeted therapies need more patients for trials
Pay Invoice
Latest Blogs
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
